key: cord-0997758-4dm4f67s
authors: Paneroni, M.; Vitacca, M.; Bernocchi, P.; Bertacchini, L.; Scalvini, S.
title: Feasibility of tele-rehabilitation in survivors of COVID-19 pneumonia
date: 2021-04-14
journal: Pulmonology
DOI: 10.1016/j.pulmoe.2021.03.009
sha: 99077115ac646b4a9230c1acf2a67f03fbc4daa3
doc_id: 997758
cord_uid: 4dm4f67s

nan

Survivors of COVID-19-associated pneumonia may experience a long-term reduction in functional capacity, exercise tolerance, and muscle strength, regardless of their previous health status or disabilities. [1] [2] [3] Telerehabilitation (TR) programs have proven effective in several conditions, [4] [5] [6] and have been also suggested for patients after COVID-19. 7 To date, however, no study has investigated whether early telerehabilitation after hospitalization for COVID-19-associated pneumonia is effective. We report a pilot study investigating the safety, feasibility, and efficacy of a 1-month TR program in individuals discharged after recovery from COVID-19 pneumonia [Ethical Committee

The study was conducted from April 1 to June 30, 2020 at the ICS Maugeri Institute of Lumezzane, Italy, a referral centre for pulmonary rehabilitation with a dedicated COVID-19 Unit. Inclusion criteria were: clinical stability; resting hypoxaemia or exercise-induced desaturation (EID) [≥4% decrease in SpO2 at the 6-min Walking Test (6MWT) 8 ], or exercise limitation (6MWT: <70% of predicted), availability of home internet and ability to use technologies. Patients with cognitive deficits, severe comorbidities or physical impairment preventing exercise without medical supervision were excluded.

On admission to the program, patients received a pulse oximeter, a brochure illustrating exercises, a diary to record daily activities, and instructions for home exercises. The one-month program consisted of one hour daily of aerobic reconditioning and muscle strengthening and healthy lifestyle education. Twice a week, a physiotherapist (PT) contacted the patientby video-call via a dedicated platformto monitor progress. Exercise intensity was based on the Short Physical Performance Battery (SPPB) 9 test and EID and was divided into 4 arbitrary levels (1= lowest intensity, 4=highest intensity). Patients with SPPB<10 or EID were included in the levels 1-2 and performed low-intensity aerobics (walking, free-body exercise, sit-to-stand) and balance exercises.

Patients with SPPB≥10 and no EID were included in the levels 3-4 and performed walking session with pedometer, aerobics with cycle ergometer or leg/arm crank, and strengthening exercises with a J o u r n a l P r e -p r o o f lightweight band. The intensity of the exercise session was progressively increased according to symptoms and cardio-respiratory parameters evaluation. Programs could be changed only under strict PT control. Chest physiotherapy exercises (lung expansion, strengthening of the respiratory muscles) could be added, if necessary. In addition to physiotherapy monitoring, for the first two weeks nurses tele-monitored patients daily to check their clinical needs; subsequently, patients received one weekly telephone/video call. If any symptoms/problems emerged, patients could always contact nurses (7/7 days) or physicians for a second-opinion consultation.

On admission to TR, anthropometrics, clinical status and lung function were collected (Table 1) .

On admission and discharge, 6MWT 8 , 1 Minute Sit-to-Stand (1MSTS) 10 The number of sit-to-stands increased in 62.5%, remained stable in 16.6%, and decreased in 20.8% of patients; 12 patients (50.0%) improved 1MSTS above the MCID (3 rises). 10 Barthel dyspnoea improved in 83.3%, remaining unchanged in 16.7% of patients; in 50% of patients, the dyspnoea decrease was 6.5 points above the MCID. 11 This preliminary report, although limited by the small sample size and absence of a control group, confirms the feasibility and safety of a dedicated TR program for survivors of COVID-19 pneumonia. After one month of TR, patients improved exercise tolerance and dyspnoea. However, approximately 20% of patients were non-responders. No adverse events were found. As with chronic cardio-pulmonary diseases, telerehabilitation may help to avoid a gap in service delivery following hospital discharge of COVID-19 patients and should be integrated into their follow-up.

Further randomized control trials are needed. Barthel dyspnoea, score 11.7±9.0

Muscle strength and physical performance in patients without previous disabilities recovering from COVID-19 Pneumonia

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Pulmonary rehabilitation in patients recovering from COVID-19. Respiration

Telemonitoring of ventilator-dependent patients: a European Respiratory Society Statement

Telemonitoring systems for respiratory patients: technological aspects

Maugeri Centre for Telehealth and Telecare: A real-life integrated experience in chronic patients

A Brief Intervention to Support Implementation of Telerehabilitation by Community Rehabilitation Services During COVID-19: A Feasibility Study

Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement

A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission

A multicentre validation of the 1-min sit-to-stand test in patients with COPD

Minimal Clinically Important Difference in Barthel Index Dyspnea in Patients with COPD